|
Abbott Diabetes Care is developing products to reduce the discomfort and
inconvenience of blood glucose monitoring; introducing systems that are easier
to use, require less blood and provide faster results.
Based in Alameda, California, Abbott Diabetes Care designs, develops and
manufactures several leading-edge glucose monitoring systems and test strips
for use in both home and hospital settings. Among its leading brands are the
FreeStyle Navigator® system,
FreeStyle Lite® system, the and the
Precision Xtra® system.
FreeStyle Freedom Lite® system
In addition to monitoring systems and diabetes management products, Abbott
Diabetes Care also focuses on educating people with diabetes on how they can
make every day choices to help themselves - and live active, healthy
lives.
Abbott entered the blood glucose monitoring marketplace with the acquisition
of MediSense in 1996. In April 2004, Abbott announced it had completed the
acquisition of TheraSense, a leader in developing blood glucose self-monitoring
devices that require very small blood samples to deliver rapid test results,
Virtually Pain-Free. The TheraSense acquisition strengthened Abbott's position
in the large and growing blood glucose monitoring market.
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The company
employs more than 65,000 people and markets its products in more than 130
countries.
 |
By Michele D. Huie
TCOYD Newsletter, Vol. 27, 2008
Almost one year ago,
the FDA approved
Abbott's FreeStyle
Navigator continuous
glucose monitoring
(“CGM”) system. There are
now three CGM devices
available in the U.S. by
prescription: MiniMed’s
Paradigm Real-Time
system, Dexcom Seven,
and Abbott Navigator.
Thankfully, more
and more insurance
companies are admitting
to the reality of this lifesaving,
life-prolonging,
and complication-deterring
tool; see related article .
|
|
 |
By Kaku Armah and Kelly Close
TCOYD Newsletter, Vol. 27, 2008
An Interview with a CGM Reimbursement Guru
Jean Corrigan RN, MA, CDE, is program director for Winthrop University Hospital’s pediatric diabetes program. This ADA nationally recognized pediatric program serves over 1000 diabetes patients, 40 percent of whom are on insulin pumps. A highly regarded diabetes educator, she has extensive experience using continuous glucose monitoring (CGM).
|
|
|
